These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2752417)
1. Interaction with normal cells suppresses the transformed phenotype of v-myc-transformed quail muscle cells. La Rocca SA; Grossi M; Falcone G; Alemà S; Tatò F Cell; 1989 Jul; 58(1):123-31. PubMed ID: 2752417 [TBL] [Abstract][Full Text] [Related]
2. Differential control of muscle-specific gene expression specified by src and myc oncogenes in myogenic cells. Falcone G; Gauzzi MC; Tatò F; Alemà S Ciba Found Symp; 1990; 150():250-8; discussion 258-61. PubMed ID: 2115425 [TBL] [Abstract][Full Text] [Related]
3. The ski oncogene induces muscle differentiation in quail embryo cells. Colmenares C; Stavnezer E Cell; 1989 Oct; 59(2):293-303. PubMed ID: 2553267 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional down-regulation of myogenin expression is associated with v-ras-induced block of differentiation in unestablished quail muscle cells. Russo S; Tatò F; Grossi M Oncogene; 1997 Jan; 14(1):63-73. PubMed ID: 9010233 [TBL] [Abstract][Full Text] [Related]
5. Distinctive effects of the viral oncogenes myc, erb, fps, and src on the differentiation program of quail myogenic cells. Falcone G; Tatò F; Alemà S Proc Natl Acad Sci U S A; 1985 Jan; 82(2):426-30. PubMed ID: 2982156 [TBL] [Abstract][Full Text] [Related]
6. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. La Rocca SA; Crouch DH; Gillespie DA Oncogene; 1994 Dec; 9(12):3499-508. PubMed ID: 7970710 [TBL] [Abstract][Full Text] [Related]
7. Selective repression of myoD transcription by v-Myc prevents terminal differentiation of quail embryo myoblasts transformed by the MC29 strain of avian myelocytomatosis virus. La Rocca SA; Vannucchi S; Pompili M; Pinney DF; Emerson CP; Grossi M; Tatò F Oncogene; 2002 Jul; 21(31):4838-42. PubMed ID: 12101422 [TBL] [Abstract][Full Text] [Related]
8. Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiation-defective myoblasts. Sejersen T; Sümegi J; Ringertz NR J Cell Physiol; 1985 Dec; 125(3):465-70. PubMed ID: 4066768 [TBL] [Abstract][Full Text] [Related]
10. v-myb dominance over v-myc in doubly transformed chick myelomonocytic cells. Ness SA; Beug H; Graf T Cell; 1987 Oct; 51(1):41-50. PubMed ID: 2820586 [TBL] [Abstract][Full Text] [Related]
11. v-jun oncogene prevents terminal differentiation and suppresses muscle-specific gene expression in ASV-17-infected muscle cells. Grossi M; Calconi A; Tatò F Oncogene; 1991 Oct; 6(10):1767-73. PubMed ID: 1923502 [TBL] [Abstract][Full Text] [Related]
12. Preparation of a monoclonal antibody and expression of its antigen associated with myogenic differentiation on spontaneous and artificial myotubes derived from avian myoblasts. Saiuchi M; Nunoura N; Kim J Cell Struct Funct; 1993 Oct; 18(5):285-96. PubMed ID: 7513264 [TBL] [Abstract][Full Text] [Related]
14. Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells. Crescenzi M; Crouch DH; Tatò F J Cell Biol; 1994 Jun; 125(5):1137-45. PubMed ID: 8195295 [TBL] [Abstract][Full Text] [Related]
15. Specific viral oncogenes cause differential effects on cell-to-cell communication, relevant to the suppression of the transformed phenotype by normal cells. Bignami M; Rosa S; Falcone G; Tató F; Katoh F; Yamasaki H Mol Carcinog; 1988; 1(1):67-75. PubMed ID: 2475135 [TBL] [Abstract][Full Text] [Related]
16. Suppression in transformed avian fibroblasts of a gene (crp) encoding a cysteine-rich protein containing LIM domains. Weiskirchen R; Bister K Oncogene; 1993 Sep; 8(9):2317-24. PubMed ID: 8361751 [TBL] [Abstract][Full Text] [Related]
17. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels. Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454 [TBL] [Abstract][Full Text] [Related]